Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation

被引:131
作者
Ikezumi, Y
Hurst, LA
Masaki, T
Atkins, RC
Nikolic-Paterson, DJ
机构
[1] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Monash Med Ctr, Clayton, Vic 3168, Australia
基金
英国医学研究理事会;
关键词
macrophage; adoptive transfer; proteinuria; proliferation; mesangial; immunosuppression; glomerular disease;
D O I
10.1046/j.1523-1755.2003.00717.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Glomerular macrophage accumulation is a feature of proliferative human and experimental glomerulonephritis. However, our understanding of the role of macrophages in the induction of renal injury is based upon indirect evidence from depletion studies, most of which lack specificity for this cell type. Therefore, an adoptive transfer approach was used to directly assess the potential of macrophages to induce renal injury. Methods. Accelerated anti-glomerular basement membrane (anti-GBM) disease was induced in rats by immunization with sheep IgG (day -5), followed by administration of sheep anti-rat GBM serum (day 0), with animals killed on day 2. To facilitate the adoptive transfer studies, immunized animals were made leukopenic by cyclophosphamide (CyPh) given on day -2. Bone marrow-derived (BM) or NR8383 macrophages were transferred by tail vein injection 24 hours after injection of anti-GBM serum, with animals killed 3 or 24 hours after transfer. Results. Pretreatment with CyPh prevented glomerular leukocyte accumulation and completely inhibited proteinuria, glomerular cell proliferation and hypercellularity in accelerated anti-GBM disease. Adoptive transfer led to significant glomerular accumulation of BM or NR8383 macrophages within 3 hours of injection, and this was still evident 24 hours later. Adoptive transfer of BM or NR8383 macrophages induced proteinuria (63 +/- 16 BM vs. 5 +/- 2 mg/24 h CyPh control; P < 0.001), glomerular cell proliferation (5.1 +/- 1.2 BM vs. 0.5 +/- 0.1 PCNA+ cells/gcs CyPh; P < 0.001) and glomerular hypercellularity (51.2 +/- 2.0 BM vs. 41.9 +/- 0.9 nuclei/gcs CyPh; P < 0.001). The degree of renal injury correlated with the number of transferred glomerular macrophages. Two-color immunostaining demonstrated that most glomerular proliferative cell nuclear antigen+ (PCNA+) proliferating cells were OX-7+ mesangial cells. CyPh treatment did not prevent up-regulation of glomerular intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1) expression or an increase in urinary monocyte chemoattractant protein-1 (MCP-1) excretion. Conclusion. This study provides the first direct evidence that macrophages can induce renal injury in terms of proteinuria and mesangial cell proliferation.
引用
收藏
页码:83 / 95
页数:13
相关论文
共 51 条
  • [1] SIGNIFICANCE OF MONONUCLEAR PHAGOCYTES IN IGA NEPHROPATHY
    ARIMA, S
    NAKAYAMA, M
    NAITO, M
    SATO, T
    TAKAHASHI, K
    [J]. KIDNEY INTERNATIONAL, 1991, 39 (04) : 684 - 692
  • [2] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [3] ATKINS RC, 1976, LANCET, V1, P830
  • [4] SUBLETHAL X-IRRADIATION DURING ACUTE PUROMYCIN NEPHROSIS PREVENTS LATE RENAL INJURY - ROLE OF MACROPHAGES
    DIAMOND, JR
    PESEKDIAMOND, I
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (06): : F779 - F786
  • [5] DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
  • [6] Feith GW, 1997, EXP NEPHROL, V5, P301
  • [7] THE DETECTION OF MONOCYTES IN HUMAN GLOMERULONEPHRITIS
    FERRARIO, F
    CASTIGLIONE, A
    COLASANTI, G
    DIBELGIOIOSO, GB
    BERTOLI, S
    DAMICO, G
    [J]. KIDNEY INTERNATIONAL, 1985, 28 (03) : 513 - 519
  • [8] GLOMERULAR CELL-PROLIFERATION AND PDGF EXPRESSION PRECEDE GLOMERULOSCLEROSIS IN THE REMNANT KIDNEY MODEL
    FLOEGE, J
    BURNS, MW
    ALPERS, CE
    YOSHIMURA, A
    PRITZL, P
    GORDON, K
    SEIFERT, RA
    BOWENPOPE, DF
    COUSER, WG
    JOHNSON, RJ
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (02) : 297 - 309
  • [9] HARA M, 1991, LAB INVEST, V65, P168
  • [10] HELMKE RJ, 1987, IN VITRO CELL DEV B, V23, P567